Background
==========

The incidence of excessive postoperative bleeding and transfusion requirements for major cardiac surgical interventions varies between 10% and 70%. Not all the mechanisms involved are as yet understood.

Objective
=========

To investigate the possible role of several genetic polymorphisms associated with coagulation, fibrinolysis and inflammation, in patients with excessive bleeding after elective cardio-pulmonary bypass (CPB).

Patients and methods
====================

We performed a cross-sectional study of 26 patients, from a clinical trial of 50 CPB patients, who did not receive antifibrinolytic prophylaxis. For these patients we recorded clinical variables associated with bleeding, and the following polymorphisms: insertion/deletion (I/D) of angiotensin-converting enzyme (ACE) gene; G1691A of the Leiden factor gene; G20210A of the factor II gene; 4G/5G of plasminogen activator inhibitor-1 (PAI-1); Alu repeat I/D of the plasminogen tissular activator (tPA) gene; and finally the first intron of TNF-β (TNF-β + 250). In addition, seven neutral markers were genotyped to follow genomic control strategies that would detect spurious associations due to population substructure \[[@B1]\]. The neutral markers chosen are biallelic Alu repeats distributed in different chromosomes. We used SPSS-12.2 software for statistical purposes.

Results
=======

Greater bleeding in the 24-hour postoperative period was associated with: ACE (DD: 891 \[SD 531\] ml; ID: 512 \[SD 458\] ml, II: 1125 \[SD 735\] ml; *P*= 0.046), TNF-β + 250 (AA: 747 \[SD 459\] ml; AG: 568 \[SD 482\] ml; GG: 1350 \[SD 775\] ml; *P*= 0.029), and PAI-1 (4G/4G: 792 \[SD 477\] ml; 4G/5G: 554 \[SD 376\] ml; 5G/5G: 1036 \[SD 694\] ml; *P*= 0.037). Homozygous 5G showed lower levels of PAI-1 (36.98 \[7.68\] vs 120.3 \[14.3\], *P*= 0.02), lower levels of leptins preoperatively (11.15 \[2.15\] vs 25.56 \[3.93\], *P*= 0.016), at admission (3.54 \[0.84\] vs 18.67 \[3.72\], *P*= 0.02), and at 4 hours (3.43 \[1.12\] vs 15.48 \[3.27\], *P*\< 0.001) and 24 hours postoperatively (11.12 \[4.36\] vs 29.57 \[4.82\], *P*= 0.013) and greater coagulation factors consumed. Those patients achieved a greater advantage of antifibrinolytic prophylaxis with tranexamic acid.

Conclusion
==========

We found three polymorphisms associated with excessive postoperative bleeding. This may enable us to identify patients at risk before CPB intervention and to optimize prophylactic therapy.
